Want to join the conversation?
$CMI cuts 2015 revenue guidance to range of flat to down 2% from previous forecast of 2-4%. $CMI lowered its 2015 EBIT outlook to range of 12.75-13% of sales, excluding costs associated with restructuring and other cost reduction actions, from previous forecast of 13.5-14%.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)